The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking trends? Be the first to know when the EU drugs agency (EMCDDA) launches its European Drug Report 2020: Trends and Developments in a live online media event on 22 September.
Background: this is the 6th EMCDDA webinar on the Coronavirus. It will be exploring with the help of three experts from Northern, Central, Southern European EU countries (Finland, Greece and The Netherlands) whether the COVID-19 related emergency is having or is going to have any impact on Drugs Policy.
This is the fourth EMCDDA webinar on the coronavirus and will be based on a recent Trendspotter exercise on drug use.
A conversation with:
The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for discussion on emerging challenges.
The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for discussion on emerging challenges.
